immunostimulation
Showing 1 - 25 of 38
Liver Metastasis Colon Cancer Trial in Aarhus (RFA (radiofrequency ablation))
Recruiting
- Liver Metastasis Colon Cancer
- RFA (radiofrequency ablation)
-
Aarhus, DenmarkAarhus University Hospital, Department of Surgery
Nov 16, 2022
Allergic Rhinitis Due to Grass Pollen Trial in Lublin (Ismigen, Placebo)
Completed
- Allergic Rhinitis Due to Grass Pollen
- Ismigen
- Placebo
-
Lublin, PolandDepartment of Pulmonary Diseases and Children Rheumatology, Medi
Apr 2, 2022
Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- Interferon gamma
- Placebo
-
Lyon, France
- +6 more
May 2, 2023
Spinal Cord Injuries, Urinary Tract Infections Trial in Nottwil (Uro-Vaxom, Placebo oral tablet)
Recruiting
- Spinal Cord Injuries
- Urinary Tract Infections
- Uro-Vaxom
- Placebo oral tablet
-
Nottwil, LU, SwitzerlandSwiss Paraplegic Centre
Jan 26, 2022
Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)
Completed
- Coronavirus
- +2 more
- LD Vehicle-GNP
- +3 more
-
Lausanne, Vaud, SwitzerlandCenter for Primary Care and Public Health (Unisante)
Nov 28, 2022
Primarily Resectable Pancreatic Cancer Trial in Heidelberg (neoadjuvant photon radiation)
Completed
- Primarily Resectable Pancreatic Cancer
- neoadjuvant photon radiation
-
Heidelberg, Germany
- +1 more
Jun 7, 2021
Metastatic Castrate Resistant Prostate Cancer Trial in Worldwide (Masitinib, Docetaxel, Prednisone)
Completed
- Metastatic Castrate Resistant Prostate Cancer
- Masitinib
- +3 more
-
Sherbrooke, Canada
- +8 more
Jun 3, 2021
Allergic Rhinitis Trial in Lublin (Ismigen, Placebo)
Completed
- Allergic Rhinitis
- Ismigen
- Placebo
-
Lublin, PolandDepartment of Pulmonary Diseases and Children Rheumatology, Medi
Apr 2, 2022
Immunophenotyping of Metastases From Colorectal Cancer
Completed
- Metastatic Colorectal Cancer
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 19, 2020
Locally Advanced or Metastatic Pancreatic Cancer Trial in Worldwide (Masitinib, Gemcitabine, Placebo)
Completed
- Locally Advanced or Metastatic Pancreatic Cancer
- Masitinib
- +2 more
-
Brugge, Belgium
- +8 more
Dec 7, 2020
Leiomyosarcoma Metastatic Trial in Korea, Republic of (Avelumab and Gemcitabine)
Unknown status
- Leiomyosarcoma Metastatic
- Avelumab and Gemcitabine
-
Busan, Korea, Republic of
- +5 more
Feb 2, 2021
COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)
Recruiting
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +3 more
-
Alken, Belgium
- +30 more
Feb 7, 2022
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Immune Response, Respiratory Diseases Trial in Granada (Combination of plant extracts (BSL_EP027), Placebo)
Completed
- Immune Response
- Respiratory Diseases
- Combination of plant extracts (BSL_EP027)
- Placebo
-
Granada, SpainClaret Nursing home
May 12, 2020
Pediatric Sepsis-induced MODS Trial in United States (GM-CSF)
Active, not recruiting
- Pediatric Sepsis-induced MODS
-
Los Angeles, California
- +7 more
Feb 24, 2022
Melanoma Trial in Ciudad Autónoma de Buenos Aires (Suicide plus immunogene therapy)
Terminated
- Melanoma
- Suicide plus immunogene therapy
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, ArgentinaHospital Italiano
Feb 21, 2020
Stem Cell, Gonarthrosis Trial in Melikgazi (Wharton Jelly Originated Mesencimal Stem Cell)
Unknown status
- Stem Cell
- Gonarthrosis
- Wharton Jelly Originated Mesencimal Stem Cell
-
Melikgazi, Kayseri, TurkeyErciyes University Faculty of Medicine
Mar 17, 2020
Post-stroke Immunological Changes in Young Stroke Patients
Not yet recruiting
- Stroke, Ischemic
- Cognitive Decline
- Analysis of T-lymphocytes
- (no location specified)
Dec 2, 2019
Chronic Hepatitis B Trial in Chisinau (REP 2139-Mg, Pegasys, Viread)
Completed
- Chronic Hepatitis B
- REP 2139-Mg
- +3 more
-
Chisinau, Moldova, Republic of
- +2 more
Sep 9, 2019
Breast Cancer Female Trial in Bogota (Peptide pulsed Dendritic cell)
Completed
- Breast Cancer Female
- Peptide pulsed Dendritic cell
-
Bogota, Cundinamarca, ColombiaFacultad de Medicina - Universidad Nacional de Colombia
May 4, 2021